Lidocaine and Ketamine Levels in Plasma After Simultaneous Lidocaine/Ketamine Infusions
CompletedNCT05906121
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this monocentric observational pilot study is to measure the lidocaine plasma level in a limited number of patients to generate explorative data on inter- and intrapersonal stability and safety of drug plasma levels and to investigate whether higher plasma levels of ketamine can be correlated with a better analgesic effect.
Study details
- Official title
- Lidocaine and Ketamine Levels in Plasma After Simultaneous Lidocaine/Ketamine Infusions. An Observational Assessment of Therapy Effects and Side-effects.
- Conditions
- Interventions
- Drug: lidocaine-ketamine infusions
- Sponsor
- University Hospital, Basel, Switzerland
- Start date
- 2023-05-16
- Primary completion
- 2024-08-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Switzerland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient is a new recipient of lidocaine-ketamine infusions * Patient is able to provide Informed Consent Exclusion Criteria: * Contraindication to blood sampling (on arm not used for infusion) * Insufficient knowledge of German language * Inability to give consent * Patient is under 18 years of age * Contraindication to treatment with lidocaine and/or ketamine
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05906121